☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Improved Results
Pfizer Reports Improved Results of P-III OA (A4091056) Study of Tanezumab in Patients with Osteoarthritis (OA)
October 25, 2018
Load more...
Back to Home